VBI Vaccines
VBIV
#10524
Rank
A$2.83 M
Marketcap
A$0.09877
Share price
0.00%
Change (1 day)
-89.95%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$15.34. In 2022 the company made an earnings per share (EPS) of A-$19.97 a decrease over its 2021 EPS that were of A-$12.25.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$19.9762.96%
2021A-$12.2528.57%
2020A-$9.53-54.35%
2019A-$20.87-52.58%
2018A-$44.0210.23%
2017A-$39.9314.29%
2016A-$34.94-62.8%
2015A-$93.9390.68%
2014A-$49.26-7.95%
2013A-$53.52-57.97%
2012A-$127.35-78%
2011A-$578.953151.47%
2010A-$17.8123.87%
2009A-$14.37-18.48%
2008A-$17.6312.08%
2007A-$15.73-49.47%
2006A-$31.14
2005N/A-100%
2004A-$13.8411.94%
2003A-$12.37-81.89%
2002A-$68.28196.44%
2001A-$23.0384.33%
2000A-$12.50-65.37%
1999A-$36.09-29.45%
1998A-$51.1529.61%
1997A-$39.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.44-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.55-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.55-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA